| 证券代码：603707 | 证券简称：健友股份 | 公告编号：2025-075 | | --- | --- | --- | | 债券代码：113579 | 债券简称：健友转债 | | 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 一、监事会会议召开情况 南京健友生化制药股份有限公司（以下简称"公司"或"本公司"）第五届 监事会第十一次会议的通知已于 2025 年 10 月 15 日以电话及电子邮件的方式向 各位监事发出，会议于 2025 年 10 月 24 日上午 10 点在公司会议室召开。会议应 到监事 3 人，实到监事 2 人。监事王慧梅女士因个人原因无法出席，委托监事刘 祖清代为出席并投票表决。 会议由监事会主席刘祖清先生主持。本次会议召集、召开符合《中华人民共 和国公司法》及有关法律、法规和《公司章程》的规定。会议审议并通过了如下 议案： 二、监事会会议审议情况 会议审议并通过了如下议案： （一）审议通过了《关于公司 2025 年三季度报告的议案》 全体监事保证 2025 年三季度报告所载不存在任何虚假性记 ...

| 证券代码：603707 | 证券简称：健友股份 | 公告编号：2025-074 | | --- | --- | --- | | 债券代码：113579 | 债券简称：健友转债 | | 南京健友生化制药股份有限公司 第五届董事会第十五次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 一、董事会会议召开情况 南京健友生化制药股份有限公司（以下简称"公司"）第五届董事会第十五 次会议的通知已于 2025 年 10 月 15 日以电话及电子邮件的方式向各位董事发出， 会议于 2025 年 10 月 24 日上午 9 点整在公司会议室召开。会议应到董事 6 人， 实到董事 5 人，其中独立董事 1 人。独立董事金毅先生因个人原因无法出席，委 托独立董事崔国庆先生代为出席并投票表决。 本次会议由董事长唐咏群先生主持。本次会议召集、召开符合《中华人民共 和国公司法》及有关法律、法规和《公司章程》的规定。 二、董事会会议审议情况 会议审议并通过了如下议案： （一）审议通过了《关于公司 2025 年三季度报告的议案》 本 ...

Financial Performance - The company's operating revenue for the third quarter was CNY 945,898,414, representing a year-on-year increase of 0.06%[4] - The total profit for the quarter was CNY 151,928,051.88, a decrease of 38.56% compared to the same period last year[4] - The net profit attributable to shareholders was CNY 143,199,605.86, down 28.67% year-on-year[4] - The net profit after deducting non-recurring gains and losses was CNY 123,973,705.84, reflecting a decrease of 30.95% compared to the previous year[4] - The basic earnings per share for the quarter was CNY 0.09, down 25.00% year-on-year[5] - Total revenue for the first three quarters of 2025 was CNY 2,925,743,881.48, a decrease of 5.3% compared to CNY 3,088,009,007.42 in the same period of 2024[18] - Net profit for the first three quarters of 2025 was CNY 429,455,986.44, down 29.1% from CNY 605,775,481.17 in the previous year[19] - The company reported a total comprehensive income of CNY 429,971,758.03, down from CNY 613,080,783.94 in the previous year[20] - Basic earnings per share decreased to CNY 0.27 from CNY 0.37, a decline of 27.0%[20] Cash Flow and Assets - The cash flow from operating activities for the year-to-date was CNY 900,324,655.05, a decline of 14.67% compared to the same period last year[5] - The company reported cash and cash equivalents of ¥1,447,642,112.17 as of September 30, 2025, an increase from ¥1,024,384,215.58 on December 31, 2024, representing a growth of approximately 41.3%[14] - The total current assets amounted to ¥7,530,416,166.22 as of September 30, 2025, compared to ¥7,045,889,981.21 at the end of 2024, indicating an increase of about 6.9%[15] - Non-current assets totaled ¥2,777,039,115.22 as of September 30, 2025, up from ¥2,464,060,382.73, marking an increase of approximately 12.7%[15] - The ending balance of cash and cash equivalents increased to ¥1,315,566,941.98 from ¥626,536,891.47, marking a significant rise of 110.0%[24] Shareholder Information - The company reported a total of 29,213 ordinary shareholders at the end of the reporting period[11] - The company has a significant shareholder structure, with the largest shareholder, Xie Juhua, holding 27.21% of shares, followed by Jiangsu Coastal Development Group with 21.3%[12] - Tang Yongqun, an overseas individual shareholder, holds 19.8% of shares, with 42,841,500 shares pledged[12] - The company has no significant changes in the participation of major shareholders in margin trading and securities lending activities[13] Operational Insights - The decline in profit was primarily due to reduced selling prices of certain products and an increase in period expenses[9] - The company has not reported any significant operational issues during the reporting period[14] - The company continues to focus on expanding its market presence and enhancing its product offerings through ongoing research and development efforts[14] - Research and development expenses rose to CNY 260,994,913.06, an increase of 20.7% compared to CNY 216,228,047.16 in 2024[19] Liabilities and Costs - Total operating costs increased to CNY 2,589,795,987.83, up 6.6% from CNY 2,430,007,182.20 year-over-year[18] - Total liabilities rose to CNY 3,556,274,956.94, up from CNY 3,021,793,728.13, marking an increase of 17.7%[16]

Core Insights - As of October 22, a total of 91 stocks in the Shanghai and Shenzhen markets have experienced net buying from major funds for five consecutive days or more [1] - The stock with the longest streak of net buying is Jianyou Co., which has seen net purchases for 13 consecutive trading days [1] - Other notable stocks with significant net buying days include Yongmaotai, Jingwei Hengrun, Shengquan Group, Zhongwen Media, Yibin Paper, Baofeng Energy, Hanghua Co., and Donghua Testing [1]

Core Viewpoint - As of October 21, a total of 82 stocks in the Shanghai and Shenzhen markets have experienced net buying from major funds for five consecutive days or more, indicating strong investor interest in these stocks [1] Group 1: Stocks with Significant Net Buying - The stock with the longest consecutive net buying days is Jianyou Co., which has seen net buying for 12 consecutive trading days [1] - Other notable stocks with significant net buying days include Jingwei Hengrun, Yongmaotai, Baihe Co., ST Chuangyi, Zhongwen Media, Renfu Pharmaceutical, Ruimaite, and Chenguang Co. [1]

看着Wind数据最新公布的84只连续获主力资金净买入的个股名单，我的手指在凯盛科技和健友股份这两个名字上来回摩 挲。作为量化投资的忠实拥趸，这种"连续10日净买入"的数据本该让我兴奋，但十年的市场历练却让我嗅到了一丝异样的 气息。 左侧那只股票虽然在调整期间跌幅惊人，但量化数据显示机构资金从未离场（图中橙色柱体持续活跃）；而右侧股票反弹 时看似强势，"机构库存"数据却早已归零。这就像看一场魔术表演——普通人只看到魔术师手上的扑克牌忽隐忽现，而量 化数据却能让我们看穿幕布后的机关暗道。 记得2025年4月那会儿，上证指数才开始它的700点征程时，市场还是一片谨慎。如今医药、科技板块的这波行情，表面看 是基本面的胜利，实则暗藏玄机。我盯着屏幕上跳动的K线，突然想起钱钟书先生在《围城》里那句："城里的人想出去， 城外的人想进来"——这不正是当下股民们的真实写照吗？ 在这个被称为"流动性牛市"的特殊时期，我见过太多朋友陷入"双面挨抽"的窘境：自己持有的股票纹丝不动，别人家的却 涨得风生水起；好不容易下定决心调仓换股，结果卖出的开始补涨，买进的却开启下跌模式。这种痛苦，就像同时被左右 开弓扇耳光。 为什么会出现这种诡异 ...

Core Insights - As of October 17, a total of 84 stocks in the Shanghai and Shenzhen markets have experienced net buying from major funds for five consecutive days or more [1] - The stocks with the longest streak of net buying are Kaisheng Technology and Jianyou Co., both of which have seen net buying for 10 consecutive trading days [1] - Other notable stocks with significant net buying days include Wuxi Zhenhua, Jintou Chengkai, Zhucheng Technology, Lianyu Co., Yongmaotai, Yan'ao Co., Aohua Endoscopy, and Kesi Technology [1]

Core Insights - As of October 16, a total of 78 stocks in the Shanghai and Shenzhen markets have experienced net buying from major funds for five consecutive days or more [1] - The stocks with the longest streak of net buying are Kaisheng Technology, Wanxin Media, Jianyou Co., and Jinling Hotel, each having received net buying for nine consecutive trading days [1] - Other notable stocks with significant net buying days include Tiancheng Technology, China Electric Research, Junpu Intelligent, Hangxin Technology, Dongpeng Holdings, Shandong Publishing, Tongkun Co., and Yuanfang Information [1]

Core Insights - As of October 15, a total of 74 stocks in the Shanghai and Shenzhen markets have experienced net buying from major funds for five consecutive days or more [1] Group 1: Stocks with Longest Net Buying - The stocks with the longest consecutive net buying days are Wanxin Media, Jianyou Co., Jinling Hotel, Jinchun Co., and Kaisheng Technology, each having recorded net buying for eight consecutive trading days [1] Group 2: Other Notable Stocks - Other stocks with significant net buying days include Guanshi Technology, Haoneng Co., Ruidi Zhichu, Hangxin Technology, Tiancheng Technology, China Electric Research, Zhangzhou Development, and Junpu Intelligent [1]

| 证券代码：603707 | | --- | | 证券简称：健友股份 公告编号：2025-073 | 本次回购资金总额不低于人民币 2,000 万元（含）且不超过人民币 4,000 万 元（含），本次回购股份的价格不超过 18.75 元/股（含），本次回购的股份用于 员工持股计划或股权激励，回购股份实施期限为自公司股东大会审议通过本次回 购股份方案之日起 12 个月内。具体内容详见公司于 2025 年 4 月 29 日披露的《健 友股份关于以集中竞价交易方式回购股份的预案》（公告编号：2025-028）。 二、回购股份的进展情况 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： | 回购方案首次披露日 | 2025/4/29，由董事长唐咏群先生提议 | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 回购方案实施期限 | 2025 年 月 20 5 | 5 | 日~2026 | 年 | 月 | 19 日 | | 预计回购金额 | 2,000万元~4 ...